Trials / Conditions / Methamphetamine Dependence

Methamphetamine Dependence

83 registered clinical trials studyying Methamphetamine Dependence — 10 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Glutide for Ending Methamphetamine NCT07204249	San Francisco Department of Public Health	Phase 2
Recruiting	Feasibility of Long-term, High-dose Stimulant for Methamphetamine Use Disorder NCT06788587	Centre hospitalier de l'Université de Montréal (CHUM)	Phase 2
Recruiting	Role of Pavlovian Mechanisms for Control Over Substance Use NCT06701487	Technische Universität Dresden	—
Recruiting	Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder NCT06233799	National Institute on Drug Abuse (NIDA)	Phase 3
Unknown	ACT for Methamphetamine Use Disorder in Women and Gender Non-Conforming Individuals NCT05334914	Centre for Addiction and Mental Health	N/A
Active Not Recruiting	MHealth Incentivized Adherence Plus Patient Navigation NCT06027814	University of Washington	N/A
Recruiting	Clinical Trial of High Dose Lisdexamfetamine and Contingency Management in MA Users NCT05854667	Centre hospitalier de l'Université de Montréal (CHUM)	Phase 2
Recruiting	Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders NCT06434818	Evon Medics LLC	Phase 2
Terminated	Monthly Injectable BUP for MA Use Disorder (MURB) Trial NCT05283304	Madhukar H. Trivedi, MD	Phase 2
Terminated	Multiple-Dose Study to Evaluate the Safety and Efficacy of IXT-m200 NCT05034874	InterveXion Therapeutics, LLC	Phase 2
Active Not Recruiting	Inflammation in Methamphetamine and STIs (IMSTI) NCT05162391	University of California, Los Angeles	N/A
Completed	rTMS for Stimulant Use Disorders NCT04907357	Medical University of South Carolina	N/A
Recruiting	PRevention Of Methamphetamine Use Among Postpartum Women Trial (PROMPT) NCT05128071	University of Utah	EARLY_Phase 1
Recruiting	Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives NCT04927143	Wake Forest University Health Sciences	N/A
Completed	Contingency Management for PrEP Adherence and/or Methamphetamine Use NCT04563962	University of California, Los Angeles	N/A
Completed	Delivering Contingency Management in Outpatient Addiction Treatment NCT04544124	University of Calgary	N/A
Completed	Effect of Methamphetamine on Residual Latent HIV Disease Study NCT03825536	University of California, San Francisco	Phase 4
Completed	Pilot TMS for Methamphetamine Use Disorder NCT04449055	Ryan M. Carnahan	N/A
Active Not Recruiting	The Human Stress Response in a Simulated ED Setting NCT04317482	University of Arkansas	N/A
Unknown	The Effect of Mindfulness-based Relapse Prevention on Impulsive Control Circuit Among Methamphetamine Dependen NCT03748875	Shanghai Mental Health Center	N/A
Completed	Repetitive dTMS Intervention for Methamphetamine Addiction NCT04202926	Shanghai Mental Health Center	N/A
Completed	Effects of Genotype on Resting State Connectivity During Methamphetamine Administration NCT03973489	Oregon Health and Science University	Phase 4
Unknown	Paired Associative Stimulation in Methamphetamine Addiction NCT03910608	Shanghai Mental Health Center	N/A
Completed	Pilot Study of the Effect of Ibudilast on Neuroinflammation in Methamphetamine Users NCT03341078	VA Office of Research and Development	Phase 2
Unknown	Transcranial Direct Current Stimulation (tDCS) Combined With Computerized Cognitive Addiction Therapy(CCAT) an NCT04139148	Shanghai Mental Health Center	N/A
Completed	Transcranial Magnetic Stimulation for Treatment of Methamphetamine Dependence NCT03827785	Shanghai Mental Health Center	N/A
Completed	Stimulant Use and Methylation in HIV NCT05916989	Florida International University	—
Completed	Study of Antibody for Methamphetamine Outpatient Therapy NCT03336866	InterveXion Therapeutics, LLC	Phase 1 / Phase 2
Recruiting	rTMS for Craving in Methamphetamine Use Disorder NCT03470480	Oregon Health and Science University	N/A
Recruiting	Creatine for Depressed Male and Female Methamphetamine Users NCT02568878	Montana State University	Phase 3
Completed	Pilot Study of Entacapone for Methamphetamine Abuse NCT02058966	Oregon Health and Science University	EARLY_Phase 1
Completed	Clinical Efficacy of Lisdexamfetamine for Methamphetamine Dependence NCT02034201	University of Arkansas	Phase 1
Completed	Targeting GABA and Opioid Systems for a Pharmacotherapy for Methamphetamine Abuse NCT01967381	University of Kentucky	EARLY_Phase 1
Completed	Trial of Ibudilast for Methamphetamine Dependence NCT01860807	University of California, Los Angeles	Phase 2
Completed	Buspirone as a Candidate Medication for Methamphetamine Abuse NCT01843205	University of Kentucky	Phase 1
Completed	An Study of Paliperidone Extended-Release Tablets in the Treatment of Methamphetamine Dependence NCT01825928	Wei Hao	N/A
Completed	A Comparison of Paliperidone and Risperidone for Treatment of Patirnts With Methamphetamine-Associated Psychos NCT01822730	Wei Hao	Phase 4
Terminated	An Study of Aripiprazole in the Treatment of Methamphetamine Dependence NCT01813656	Wei Hao	Phase 4
Terminated	A Comparison of Risperidone and Aripiprazole for Treatment of Patirnts With Methamphetamine-Associated Psychos NCT01813643	Wei Hao	Phase 4
Unknown	Comparison of Methamphetamine-Dependent and Healthy Volunteers Using a Web-Enabled Cognitive Neuropsychologica NCT01919437	California Pacific Medical Center Research Institute	N/A
Completed	A Cognitive Behavioral Therapy-Based Text Messaging Intervention for Methamphetamine Dependence NCT01577797	New Leaf Treatment Center	Phase 1
Completed	Clinical Efficacy of Atomoxetine for Methamphetamine Dependence NCT01557569	University of Arkansas	Phase 1 / Phase 2
Completed	Varenicline for Methamphetamine Dependence NCT01365819	University of California, Los Angeles	Phase 2
Completed	A Randomized, Placebo-Controlled Trial of Modafinil for Methamphetamine Dependence NCT01354470	California Pacific Medical Center Research Institute	Phase 2
Completed	Phase 1 Naltrexone-Bupropion-Methamphetamine Interaction Study NCT01359930	National Institute on Drug Abuse (NIDA)	Phase 1
Completed	PHASE IIA: Trial of a Novel Ondansetron Formulation (OND-PR002) and Immediate-Release Methylphenidate (Ritalin NCT01377662	Tong Lee	Phase 2
Completed	Varenicline as a Treatment for Methamphetamine Dependence NCT01571167	Baylor College of Medicine	Phase 1
Completed	Safety Interaction Trial Ibudilast and Methamphetamine NCT01217970	University of California, Los Angeles	Phase 1
Unknown	Combination of Psychosocial Intervention and Slow Prosecutions for the Treatment of Methamphetamine Abuse/Depe NCT01273701	National Taiwan University Hospital	N/A
Unknown	Methylphenidate to Treat Methamphetamine Dependence NCT01044238	University of California, Los Angeles	Phase 2
Completed	NAC as a Potential Treatment for Methamphetamine Dependence NCT01063205	Baylor College of Medicine	Phase 1
Completed	Smoking-Cessation and Stimulant Treatment (S-CAST) NCT01077024	University of Cincinnati	Phase 3
Completed	Citicoline Treatment of Methamphetamine Dependence NCT00950352	Perry Renshaw	Phase 3
Withdrawn	RTI-336 as a Treatment for Methamphetamine Dependence NCT01601717	Baylor College of Medicine	Phase 1
Completed	Efficacy and Safety of CDP-choline in Patients With Methamphetamine Dependence NCT01007539	Seoul National University Hospital	Phase 3
Completed	Varenicline vs Placebo for the Treatment of Methamphetamine Dependence NCT01011829	University of California, Los Angeles	Phase 2
Completed	Studying Amphetamine Withdrawal in Humans NCT01215929	University of Arkansas	Phase 2
Terminated	Safety Assessment of Atomoxetine With MA IV Administration NCT01019707	University of California, Los Angeles	Phase 1
Completed	Study of Naltrexone for Methamphetamine Addiction NCT00984360	California Pacific Medical Center Research Institute	Phase 2
Withdrawn	Aripiprazole for Methamphetamine Dependence: Double Blind Placebo Trial NCT00728312	US Department of Veterans Affairs	Phase 4
Completed	Rivastigmine as a Treatment for Methamphetamine Dependence NCT01073319	Baylor College of Medicine	Phase 1
Completed	An ACE Inhibitor (Perindopril) or an Angiotensin Receptor Blocker (Candesartan) as a Treatment for Methampheta NCT01062451	Baylor College of Medicine	Phase 1
Terminated	Modafinil for Methamphetamine Dependence NCT00859573	University of Arkansas	Phase 2
Completed	Effects of Modafinil in Methamphetamine Dependence NCT00751023	Medical University of South Carolina	Phase 4
Completed	Intensive Motivational Interviewing for Methamphetamine Dependence NCT01071356	Public Health Institute, California	Phase 2
Completed	Study of Medical Treatment for Methamphetamine Addiction NCT00833443	University of California, Los Angeles	Phase 2
Completed	Risk and Protective Factors for Rural Methamphetamine Dependence NCT00882037	University of Nebraska	—
Completed	Transcranial Magnetic Stimulation Used to Both Measure Cortical Excitability and Explore Methamphetamine Cue C NCT01685463	Medical University of South Carolina	N/A
Completed	Open-Label Disulfiram for Methamphetamine Dependence NCT00731133	University of Arkansas	Phase 1 / Phase 2
Terminated	Safety and Efficacy Study of Vigabatrin to Treat Methamphetamine Dependence NCT00730522	Catalyst Pharmaceuticals, Inc.	Phase 2
Completed	Phase 2, Double-Blind, Placebo-Controlled Trial of Bupropion for Methamphetamine Dependence NCT00687713	National Institute on Drug Abuse (NIDA)	Phase 2
Completed	Safety Assessment of Potential Interactions Between IV Methamphetamine and Osmotic-Release Methylphenidate (OR NCT00603434	University of Cincinnati	Phase 1
Terminated	Methamphetamine-Quetiapine Interactions in Humans NCT00567866	University of Arkansas	EARLY_Phase 1
Withdrawn	Varenicline-Methamphetamine Interaction Study (2008) NCT00733967	Baylor College of Medicine	Phase 1
Completed	Phase 2, Multi-Center Trial of Modafinil for Methamphetamine Dependence NCT00520286	National Institute on Drug Abuse (NIDA)	Phase 2
Completed	Safety and Tolerability of Modafinil for Methamphetamine Dependence NCT00569374	University of Arkansas	Phase 2
Completed	Modafinil vs Placebo for the Treatment of Methamphetamine Dependence NCT00469508	University of California, Los Angeles	Phase 2
Completed	Characterizing Methamphetamine Withdrawal in Recently Abstinent Methamphetamine Users: A Pilot Study NCT00653263	University of Arkansas	—
Completed	N-Acetyl Cysteine Plus Naltrexone in Methamphetamine Dependence NCT00332605	University of Chicago	Phase 2
Unknown	Tolerability and Safety of 30, 45, and 60 mg of Sublingual Lobeline. - 1 NCT00519259	National Institute on Drug Abuse (NIDA)	Phase 1
Completed	A Trial of Long-Acting Injectable Risperidone in the Treatment of Methamphetamine Dependence NCT00284206	Seattle Institute for Biomedical and Clinical Research	Phase 2
Completed	A Randomized Control Trial Comparing Quetiapine to Risperidone in Bipolar Disorder With Stimulant Dependence NCT00227123	University of Texas Southwestern Medical Center	N/A
Unknown	Ph1 Lobeline Interaction Study - 1 NCT00439504	National Institute on Drug Abuse (NIDA)	Phase 1